How omalizumab came to be studied as a therapy for chronic spontaneous/idiopathic urticaria

被引：8
作者：
Kaplan, Allen P. [1 ]
Joseph, Kusumam [2 ]
Saini, Sarbjit S. [3 ]
机构：
[1] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA
[2] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA
[3] Johns Hopkins Univ, Dept Med, Baltimore, MD USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 2015年 / 3卷 / 04期
关键词：
D O I：
10.1016/j.jaip.2015.04.008
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：648 / 648
页数：1
相关论文
共 7 条
[1]   Effect of Anti-IgE (Omalizumab) in chronic idiopathic urticaria (CIU) patients [J].
Gober, L. M. ;
Sterba, P. M. ;
Eckman, J. A. ;
Saini, S. S. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) :S147-S147
[2]   Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy [J].
Kaplan, Allen ;
Ledford, Dennis ;
Ashby, Mark ;
Canvin, Janice ;
Zazzali, James L. ;
Conner, Edward ;
Veith, Joachim ;
Kamath, Nikhil ;
Staubach, Petra ;
Jakob, Thilo ;
Stirling, Robert G. ;
Kuna, Piotr ;
Berger, William ;
Maurer, Marcus ;
Rosen, Karin .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 132 (01) :101-109
[3]   Treatment of chronic autoimmune urticaria with omalizumab [J].
Kaplan, Allen P. ;
Joseph, Kusumam ;
Maykut, Robert J. ;
Geba, Gregory P. ;
Zeldin, Robert K. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 122 (03) :569-573
[4]   Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria [J].
Maurer, Marcus ;
Rosen, Karin ;
Hsieh, Hsin-Ju ;
Saini, Sarbjit ;
Grattan, Clive ;
Gimenez-Arnau, Ana ;
Agarwal, Sunil ;
Doyle, Ramona ;
Canvin, Janice ;
Kaplan, Allen ;
Casale, Thomas .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (10) :924-935
[5]   Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: A retrospective clinical analysis [J].
Metz, Martin ;
Ohanyan, Tatevik ;
Church, Martin K. ;
Maurer, Marcus .
JOURNAL OF DERMATOLOGICAL SCIENCE, 2014, 73 (01) :57-62
[6]   A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria [J].
Saini, Sarbjit ;
Rosen, Karin E. ;
Hsieh, Hsin-Ju ;
Wong, Dennis A. ;
Conner, Edward ;
Kaplan, Allen ;
Spector, Sheldon ;
Maurer, Marcus .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 128 (03) :567-U195
[7]   The Use of Anti-IgE Therapy Beyond Allergic Asthma [J].
Stokes, Jeffrey R. ;
Casale, Thomas B. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2015, 3 (02) :162-166
1